These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20659387)

  • 21. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk Factors for Venous Thromboembolism Among Reproductive Age Women.
    Westhoff CL; Yoon LS; Tang R; Pulido V; Eisenberger A
    J Womens Health (Larchmt); 2016 Jan; 25(1):63-70. PubMed ID: 26317174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal contraception and venous thromboembolism].
    Quijada Manuitt MÁ; Pedrós C; Quintana B; Arnau JM
    Med Clin (Barc); 2014 May; 142(9):418-9. PubMed ID: 23790579
    [No Abstract]   [Full Text] [Related]  

  • 24. [Birth control pills, surgery and casting leads to high risk of venous thrombosis in women. Better prophylaxis is needed for surgical procedures, as shown in case-control study].
    Kieler H; Persson I; Sundström A; Hedenmalm K; Odeberg J; Bergendal A
    Lakartidningen; 2013 Dec 4-17; 110(49-50):2233-7. PubMed ID: 24494395
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety and Efficacy of Contraceptive Methods for Obese and Overweight Women.
    Lotke PS; Kaneshiro B
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):647-57. PubMed ID: 26598306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OCs and VTE: a practical answer to an old question.
    Pittrof R; Sauer U
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):44; author reply 44. PubMed ID: 20067676
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined hormonal pills and thrombosis: from clinical data to media consequences].
    Lévesque H; Hanslik T
    Rev Med Interne; 2013 Aug; 34(8):453-5. PubMed ID: 23764423
    [No Abstract]   [Full Text] [Related]  

  • 28. The newer contraceptive pills and venous thromboembolism risk.
    Foran TM
    Med J Aust; 2014 Apr; 200(7):376-7. PubMed ID: 24794658
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vascular thrombosis and oral contraceptives].
    Lefèvre D; Mouroziès X; Fontan R; Hammoudi S; Becade P; Mazères F; Bastide G
    Phlebologie; 1987; 40(4):981-6. PubMed ID: 3447202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates.
    Wiegers HMG; Knijp J; van Es N; Coppens M; Klok FA; Middeldorp S; Moll S
    J Thromb Haemost; 2023 Jan; 21(1):175-178. PubMed ID: 36695380
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral contraceptives and venous thromboembolism consensus opinion from an international workshop held in Berlin, Germany in December 2009.
    Reid RL; Westhoff C; Mansour D; de Vries C; Verhaeghe J; Boschitsch E; Gompel A; Birkhäuser M; Krepelka P; Dulicek P; Iversen OE; Khamoshina M; Dezman LV; Fruzzetti F; Szarewski A; Wilken-Jensen C; Seidman D; Kaaja R; Shapiro S
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):117-22. PubMed ID: 20659363
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination oral contraceptives and the risk of venous thromboembolism.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):23-4. PubMed ID: 20336034
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
    Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
    Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contraception-related venous thromboembolism in a pediatric institution.
    Pillai P; Bonny AE; O'Brien SH
    J Pediatr Adolesc Gynecol; 2013 Jun; 26(3):186-8. PubMed ID: 23566795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study.
    Le Moigne E; Tromeur C; Delluc A; Gouillou M; Alavi Z; Lacut K; Mottier D; Le Gal G
    Haematologica; 2016 Jan; 101(1):e12-4. PubMed ID: 26452982
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral contraceptive pill and thrombotic risk: epidemiological studies].
    Fruzzetti F; Perini D; Spirito N; Manca R
    Minerva Ginecol; 2012 Dec; 64(6):539-49. PubMed ID: 23232538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug interactions with hormonal contraception.
    Guillebaud J
    J Fam Plann Reprod Health Care; 2005 Oct; 31(4):335-6; author reply 336. PubMed ID: 16274570
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral hormonal contraception and venous thromboembolism (VTE).
    Reid RL
    Contraception; 2014 Apr; 89(4):235-6. PubMed ID: 24594431
    [No Abstract]   [Full Text] [Related]  

  • 39. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
    Dunn N
    BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
    [No Abstract]   [Full Text] [Related]  

  • 40. Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism.
    Leppée M; Culig J
    J Fam Plann Reprod Health Care; 2012 Apr; 38(2):137-8. PubMed ID: 22454018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.